Table 2.
Groups | Genotype, n (%) | Allele, n (%) | Dominant model | Recessive model | ||
---|---|---|---|---|---|---|
CC+CG | GG | C | G | (CG+GG)/CC | GG/(CG+CC) | |
Control (n = 900) | 687 (76.33) | 213 (23.67) | 966 (53.67) | 834 (46.33) | 621:279 | 213:687 |
NAFLD (n = 900) | 454 (50.44) | 446 (49.56) | 701 (38.94) | 1099 (61.05) | 653:247 | 446:454 |
OR* | 1.0000 | 3.1685 | 1.0000 | 1.8159 | 1.1878 | 3.1685 |
95% CI | 1.9366–5.2073 | 1.3047–2.8671 | 0.8387–1.7593 | 1.9366–5.2073 | ||
P | 0.0069 | 0.0085 | 0.0857 | 0.0069 |
*Adjusted for sex, age, and smoking status. NAFLD: Nonalcoholic fatty liver disease; CI: Confidence interval; OR: Odds ratio.